US 11760755
Hepatitis B antiviral agents
granted A61KA61K31/519A61K31/5383
Quick answer
US patent 11760755 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/519, A61K31/5383, A61K31/5386, A61K38/21